Chemoinformaics analysis of (2R,3S,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXANOIC ACID
| Molecular Weight | 196.155 | nRot | 5 |
| Heavy Atom Molecular Weight | 184.059 | nRig | 11 |
| Exact Molecular Weight | 196.058 | nRing | 0 |
| Solubility: LogS | -4.553 | nHRing | 0 |
| Solubility: LogP | 4.546 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 23.6355 |
| nHD | 6 | BPOL | 12.9065 |
| QED | 0.669 |
| Synth | 4.262 |
| Natural Product Likeliness | 3.06 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.4 |
| MDCK | 0.0000159 |
| BBB | 0.912 |
| PPB | 0.964392 |
| VDSS | 2.023 |
| FU | 0.0348431 |
| CYP1A2-inh | 0.265 |
| CYP1A2-sub | 0.412 |
| CYP2c19-inh | 0.147 |
| CYP2c19-sub | 0.917 |
| CYP2c9-inh | 0.326 |
| CYP2c9-sub | 0.566 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.335 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.458 |
| CL | 14.707 |
| T12 | 0.072 |
| hERG | 0.025 |
| Ames | 0.032 |
| ROA | 0.149 |
| SkinSen | 0.056 |
| Carcinogencity | 0.077 |
| EI | 0.068 |
| Respiratory | 0.19 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.873031 |